Effect of vitamin C on endothelial function in health and disease: A systematic review and meta-analysis of randomised controlled trials

Atherosclerosis

Volumn 235, Issue 1, 2014, Pages 9-20

  Ashor, Ammar W ^a,b   Lara, Jose ^a   Mathers, John C ^a   Siervo, Mario ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b MUSTANSIRIYAH UNIVERSITY   (Iraq)

Author keywords

Ascorbic acid; Cardiovascular risk; Flow mediated dilation; Forearm blood flow; Nutritional supplements

Indexed keywords

ASCORBIC ACID; ANTIOXIDANT;

ATHEROSCLEROSIS; CARDIAC PATIENT; CELL FUNCTION; DIABETES MELLITUS; DRUG ADMINISTRATION ROUTE; DRUG DOSE REGIMEN; DRUG EFFECT; ENDOTHELIUM CELL; HEALTH STATUS; HEART FAILURE; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STUDY DESIGN; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; ADULT; AGED; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENT; DRUG EFFECTS; ENDOTHELIUM; FEMALE; INFLAMMATION; MALE; MIDDLE AGED; NORMAL HUMAN; REGRESSION ANALYSIS; YOUNG ADULT;

ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; ENDOTHELIUM; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84901847730     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.04.004     Document Type: Review

References (101)

1. Dahlof B. Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 2010, 105:3A-9A.
2. Pober J.S., Min W., Bradley J.R. Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 2009, 4:71-95.
3. Cangemi R., Angelico F., Loffredo L., Del Ben M., Pignatelli P., Martini A., et al. Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid. Free Radic Biol Med 2007, 43:853-859.
4. Protogerou A.D., Lekakis J.P., Kontoyanni D.D., Stamatelopoulos K.S., Papaioannou T.G., Tsotsoros N.D., et al. Acute administration of vitamin C prolongs the duration of forearm reactive hyperemia in patients with hypercholesterolemia. Hellenic J Cardiol 2002, 43:108-115.
5. Raitakari O.T., Adams M.R., McCredie R.J., Griffiths K.A., Stocker R., Celermajer D.S. Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. JAm Coll Cardiol 2000, 35:1616-1621.
6. Silvestro A., Scopacasa F., Oliva G., De Cristofaro T., Iuliano L., Brevetti G. Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis 2002, 165:277-283.
7. Versari D., Daghini E., Virdis A., Ghiadoni L., Taddei S. Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 2009, 157:527-536.
8. Forstermann U. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 2010, 459:923-939.
9. Siervo M., Stephan B.C., Feelisch M., Bluck L.J. Measurement of invivo nitric oxide synthesis in humans using stable isotopic methods: a systematic review. Free Radic Biol Med 2011, 51:795-804.
10. May J.M., Harrison F.E. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal 2013, 19(17):2068-2083.
11. Salonen R.M., Nyyssonen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T.H., et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 2003, 107:947-953.
12. Wang Y., Chun O.K., Song W.O. Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies. Nutrients 2013, 5:2969-3004.
13. Watanabe H., Kakihana M., Ohtsuka S., Sugishita Y. Randomized, double-blind, placebo-controlled study of the preventive effect of supplemental oral vitamin C on attenuation of development of nitrate tolerance. JAm Coll Cardiol 1998, 31:1323-1329.
14. Darko D., Dornhorst A., Kelly F.J., Ritter J.M., Chowienczyk P.J. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in type II diabetes. Clin Sci 2002, 103:339-344.
15. Magen E., Viskoper R., Mishal J., Priluk R., Berezovsky A., Laszt A., et al. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control. Isr Med Assoc J 2004, 6:742-746.
16. Higgins J.P.T., Green S. Guide to the contents of a cochrane protocol and review. Cochrane handbook for systematic reviews of interventions 2008, 51-79. John Wiley & Sons, Ltd.
17. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
18. Crowther M., Lim W., Crowther M.A. Systematic review and meta-analysis methodology. Blood 2010, 116:3140-3146.
19. Cummings P. Arguments for and against standardized mean differences (effect sizes). Arch Pediatr Adolesc Med 2011, 165:592-596.
20. Elbourne D.R., Altman D.G., Higgins J.P., Curtin F., Worthington H.V., Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2002, 31:140-149.
21. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
22. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
23. DuPont J.J., Farquhar W.B., Townsend R.R., Edwards D.G. Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease. JAppl Physiol 2011, 111:1561-1567.
24. Holowatz L.A., Kenney W.L. Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans. Am J Physiol Heart Circ Physiol 2007, 293:H1090-H1096.
25. Holowatz L.A., Kenney W.L. Oral atorvastatin therapy increases nitric oxide-dependent cutaneous vasodilation in humans by decreasing ascorbate-sensitive oxidants. Am J Physiol Regul Integr Comp Physiol 2011, 301:R763-R768.
26. Holowatz L.A., Thompson C.S., Kenney W.L. Acute ascorbate supplementation alone or combined with arginase inhibition augments reflex cutaneous vasodilation in aged human skin. Am J Physiol Heart Circ Physiol 2006, 291:H2965-H2970.
27. Schindler T.H., Nitzsche E.U., Munzel T., Olschewski M., Brink I., Jeserich M., et al. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. JAm Coll Cardiol 2003, 42:814-822.
28. Basili S., Tanzilli G., Mangieri E., Raparelli V., Di Santo S., Pignatelli P., et al. Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention. Relationship with oxidative stress markers. JACC: Cardiovasc Interv 2010, 3:221-229.
29. Ward N.C., Hodgson J.M., Croft K.D., Burke V., Beilin L.J., Puddey I.B. The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. JHypertens 2005, 23:427-434.
30. Gori T., Stolfo G., Sicuro S., Dragoni S., Lisi M., Forconi S., et al. Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight. Br J Clin Pharmacol 2007, 145-150.
31. Johnson B.D., Mather K.J., Newcomer S.C., Mickleborough T.D., Wallace J.P. Brachial artery flow-mediated dilation following exercise with augmented oscillatory and retrograde shear rate. Cardiovasc Ultrasound 2012, 10.
32. Kelly R.P., Poo Yeo K., Isaac H.B., Lee C.-Y.J., Huang S.H., Teng L., et al. Lack of effect of acute oral ingestion of vitamin C on oxidative stress, arterial stiffness or blood pressure in healthy subjects. Free Radic Res 2008, 42:514-522.
33. Lisi M., Dragoni S., Leone M.C., Munzel T., Parker J.D., Gori T. Acute (but not chronic) smoking paradoxically protects the endothelium from ischemia and reperfusion: insight into the "smoking paradox". Clin Res Cardiol 2013, 102:387-389.
34. Singh N., Graves J., Taylor P.D., MacAllister R.J., Singer D.R.J. Effects of a 'healthy' diet and of acute and long-term vitamin C on vascular function in healthy older subjects. Cardiovasc Res 2002, 56:118-125.
35. Wilkinson I.B., Megson I.L., MacCallum H., Sogo N., Cockcroft J.R., Webb D.J. Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. JCardiovasc Pharmacol 1999, 34:690-693.
36. Antoniades C., Tousoulis D., Tountas C., Tentolouris C., Toutouza M., Vasiliadou C., et al. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C. Diabet Med 2004, 21:552-558.
37. Schneider M.P., Delles C., Schmidt B.M.W., Oehmer S., Schwarz T.K., Schmieder R.E., et al. Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension. Am J Hypertens 2005, 18:1111-1117.
38. Ceriello A., Esposito K., Piconi L., Ihnat M., Thorpe J., Testa R., et al. Glucose "peak" and glucose "spike": impact on endothelial function and oxidative stress. Diabetes Res Clin Pract 2008, 82:262-267.
39. De Marchi S., Prior M., Rigoni A., Zecchetto S., Rulfo F., Arosio E. Ascorbic acid prevents vascular dysfunction induced by oral glucose load in healthy subjects. Eur J Intern Med 2012, 23:54-57.
40. Mullan B.A., Ennis C.N., Fee H.J.P., Young I.S., McCance D.R. Protective effects of ascorbic acid on arterial hemodynamics during acute hyperglycemia. Am J Physiol Heart Circ Physiol 2004, 287:H1262-H1268.
41. Mullan B.A., Ennis C.N., Fee H.J.P., Young I.S., McCance D.R. Pretreatment with intravenous ascorbic acid preserves endothelial function during acute hyperglycaemia (R1). Clin Exp Pharmacol Physiol 2005, 32:340-345.
42. Bayerle-Eder M., Pleiner J., Mittermayer F., Schaller G., Roden M., Waldhäusl W., et al. Effect of systemic vitamin C on free fatty acid-induced lipid peroxidation. Diabetes Metab 2004, 30:433-439.
43. Pleiner J., Schaller G., Mittermayer F., Bayerle-Eder M., Roden M., Wolzt M. FFA-induced endothelial dysfunction can be corrected by vitamin C. JClin Endocrinol Metab 2002, 87:2913-2917.
44. Pleiner J., Mittermayer F., Schaller G., MacAllister R.J., Wolzt M. High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation 2002, 106:1460-1464.
45. Pleiner J., Mittermayer F., Schaller G., Marsik C., MacAllister R.J., Wolzt M. Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress. JAm Coll Cardiol 2003, 42:1656-1662.
46. Arcaro G., Cretti A., Balzano S., Lechi A., Muggeo M., Bonora E., et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002, 105:576-582.
47. Kanani P.M., Sinkey C.A., Browning R.L., Allaman M., Knapp H.R., Haynes W.G. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 1999, 100:1161-1168.
48. Pleiner J., Schaller G., Mittermayer F., Marsik C., MacAllister R.J., Kapiotis S., et al. Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion. Atherosclerosis 2008, 197:383-391.
49. Antoniades C., Tousoulis D., Tentolouris C., Toutouza M., Marinou K., Goumas G., et al. Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers. Thromb Haemost 2003, 89:990-995.
50. Pellegrini M.P., Newby D.E., Johnston N.R., Maxwell S., Webb D.J. Vitamin C has no effect on endothelium-dependent vasomotion and acute endogenous fibrinolysis in healthy smokers. JCardiovasc Pharmacol 2004, 44:117-124.
51. Tousoulis D., Antoniades C., Tentolouris C., Tsioufis C., Toutouza M., Toutouzas P., et al. Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers. Atherosclerosis 2003, 170:261-267.
52. Anderson R.A., Evans L.M., Ellis G.R., Khan N., Morris K., Jackson S.K., et al. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes. Diabet Med 2006, 23:258-264.
53. Ceriello A., Novials A., Ortega E., Canivell S., Pujadas G., La Sala L., et al. Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes. Cardiovasc Diabetol 2013, 12:97.
54. Chen H., Karne R.J., Hall G., Campia U., Panza J.A., Cannon R.O., et al. High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol 2006, 290:H137-H145.
55. Guazzi M., Berti M., Belletti S., Reina G., Guazzi M.D. Exercise metaboreflex activation and endothelial function impairment in atrial fibrillation. Am J Physiol Heart Circ Physiol 2006, 291:H2396-H2402.
56. Lu Q., Björkhem I., Wretlind B., Diczfalusy U., Henriksson P., Freyschuss A. Effect of ascorbic acid on microcirculation in patients with Type II diabetes: a randomized placebo-controlled cross-over study. Clin Sci 2005, 108:507-513.
57. Mullan B.A., Young I.S., Fee H., McCance D.R. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 2002, 40:804-809.
58. Tousoulis D., Antoniades C., Tountas C., Bosinakou E., Kotsopoulou M., Toutouzas P., et al. Vitamin C affects thrombosis/fibrinolysis system and reactive hyperemia in patients with type 2 diabetes and coronary artery disease. Diabetes Care 2003, 26:2749-2753.
59. Tousoulis D., Antoniades C., Vasiliadou C., Kourtellaris P., Koniari K., Marinou K., et al. Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the inflammatory process in patients with type 2 diabetes mellitus. Heart 2007, 93:244-246.
60. Duffy S.J., Gokce N., Holbrook M., Hunter L.M., Biegelsen E.S., Huang A., et al. Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol 2001, 280:H528-H534.
61. Gokce N., Keaney J.F., Frei B., Holbrook M., Olesiak M., Zachariah B.J., et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999, 99:3234-3240.
62. Hamabe A., Takase B., Uehata A., Kurita A., Ohsuzu F., Tamai S. Impaired endothelium-dependent vasodilation in the brachial artery in variant angina pectoris and the effect of intravenous administration of vitamin C. Am J Cardiol 2001, 87:1154-1159.
63. Ellis G.R., Anderson R.A., Chirkov Y.Y., Morris-Thurgood J., Jackson S.K., Lewis M.J., et al. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. JCardiovasc Pharmacol 2001, 37:564-570.
64. Hornig B., Arakawa N., Kohler C., Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998, 363-368.
65. Nightingale A.K., Blackman D.J., Field R., Glover N.J., Pegge N., Mumford C., et al. Role of nitric oxide and oxidative stress in baroreceptor dysfunction in patients with chronic heart failure. Clin Sci 2003, 104:529-535.
66. Nightingale A.K., Crilley J.G., Pegge N.C., Boehm E.A., Mumford C., Taylor D.J., et al. Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure. Eur J Heart Fail 2007, 9:287-291.
67. Williams M.J.A., Sutherland W.H.F., McCormick M.P., De Jong S.A., McDonald J.R., Walker R.J. Vitamin C improves endothelial dysfunction in renal allograft recipients. Nephrol Dial Transplant 2001, 16:1251-1255.
68. Fletcher A.E., Breeze E., Shetty P.S. Antioxidant vitamins and mortality in older persons: findings from the nutrition add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Am J Clin Nutr 2003, 78:999-1010.
69. Osganian S.K., Stampfer M.J., Rimm E., Spiegelman D., Hu F.B., Manson J.E., et al. Vitamin C and risk of coronary heart disease in women. JAm Coll Cardiol 2003, 42:246-252.
70. Knekt P., Ritz J., Pereira M.A., O'Reilly E.J., Augustsson K., Fraser G.E., et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004, 80:1508-1520.
71. Frei B., Birlouez-Aragon I., Lykkesfeldt J. Authors' perspective: what is the optimum intake of vitamin C in humans?. Crit Rev Food Sci Nutr 2012, 52:815-829.
72. Cook N.R., Albert C.M., Gaziano J.M., Zaharris E., MacFadyen J., Danielson E., et al. Arandomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007, 167:1610-1618.
73. Sesso H.D., Buring J.E., Christen W.G., Kurth T., Belanger C., MacFadyen J., et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008, 300:2123-2133.
74. Michels A.J., Frei B. Myths, artifacts, and fatal flaws: identifying limitations and opportunities in vitamin C research. Nutrients 2013, 5:5161-5192.
75. Michels A.J., Hagen T.M., Frei B. Human genetic variation influences vitamin C homeostasis by altering vitamin C transport and antioxidant enzyme function. Annu Rev Nutr 2013, 33:45-70.
76. May J.M. How does ascorbic acid prevent endothelial dysfunction?. Free Radic Biol Med 2000, 28:1421-1429.
77. Padayatty S.J., Katz A., Wang Y., Eck P., Kwon O., Lee J.H., et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. JAm Coll Nutr 2003, 22:18-35.
78. d'Uscio L.V., Milstien S., Richardson D., Smith L., Katusic Z.S. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 2003, 92:88-95.
79. Muller-Delp J.M. Ascorbic acid and tetrahydrobiopterin: looking beyond nitric oxide bioavailability. Cardiovasc Res 2009, 84:178-179.
80. Murphy M.E. Ascorbate and dehydroascorbate modulate nitric oxide-induced vasodilations of rat coronary arteries. JCardiovasc Pharmacol 1999, 34:295-303.
81. Halliwell B. Oxidative stress in cell culture: an under-appreciated problem?. FEBS Lett 2003, 540:3-6.
82. Lindblad M., Tveden-Nyborg P., Lykkesfeldt J. Regulation of vitamin C homeostasis during deficiency. Nutrients 2013, 5:2860-2879.
83. Frikke-Schmidt H., Lykkesfeldt J. Role of marginal vitamin C deficiency in atherogenesis: invivo models and clinical studies. Basic Clin Pharmacol Toxicol 2009, 104:419-433.
84. Levine M., Padayatty S.J., Espey M.G. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr 2011, 2:78-88.
85. Monsen E.R. Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. JAm Diet Assoc 2000, 100:637-640.
86. Brubacher D., Moser U., Jordan P. Vitamin C concentrations in plasma as a function of intake: a meta-analysis. Int J Vitam Nutr Res 2000, 70:226-237.
87. Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109:III27-32.
88. Price K.D., Price C.S., Reynolds R.D. Hyperglycemia-induced latent scurvy and atherosclerosis: the scorbutic-metaplasia hypothesis. Med Hypotheses 1996, 46:119-129.
89. Wilson J.X. Regulation of vitamin C transport. Annu Rev Nutr 2005, 25:105-125.
90. Shantsila E., Wrigley B.J., Blann A.D., Gill P.S., Lip G.Y. Acontemporary view on endothelial function in heart failure. Eur J Heart Fail 2012, 14:873-881.
91. Fischer D., Rossa S., Landmesser U., Spiekermann S., Engberding N., Hornig B., et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 2005, 26:65-69.
92. Conney A.H., Reidenberg M.M. Cigarette smoking, coffee drinking, and ingestion of charcoal-broiled beef as potential modifiers of drug therapy and confounders of clinical trials. JPharmacol Exp Ther 2012, 342:9-14.
93. Solzbach U., Hornig B., Jeserich M., Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997, 96:1513-1519.
94. Taddei S., Virdis A., Ghiadoni L., Magagna A., Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998, 97:2222-2229.
95. Juraschek S.P., Guallar E., Appel L.J., Miller E.R. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2012, 95:1079-1088.
96. Houston M.C. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis 2010, 4:165-183.
97. Neunteufl T., Heher S., Katzenschlager R., Wolfl G., Kostner K., Maurer G., et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000, 86:207-210.
98. Modena M.G., Bonetti L., Coppi F., Bursi F., Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. JAm Coll Cardiol 2002, 40:505-510.
99. Inaba Y., Chen J.A., Bergmann S.R. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging 2010, 26:631-640.
100. Nuesch E., Trelle S., Reichenbach S., Rutjes A.W., Tschannen B., Altman D.G., et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010, 341:c3515.
101. Lau J., Ioannidis J.P., Terrin N., Schmid C.H., Olkin I. The case of the misleading funnel plot. BMJ 2006, 333:597-600.